NASDAQ: TNGX Tango Therapeutics, Inc. 8-K

Tango Therapeutics announces two director resignations alongside Q1 2026 earnings release

Filed May 13, 2026 · Period ending May 13, 2026 · ~1 min read

3 material changes detected in this filing.

Create a free account to read the full summary — it takes 30 seconds.

Partner

Trade TNGX commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

Generated by AI · Jun 5, 2026 4:12 PM